In part, the 2023-24 crunch was made worse because the market was dominated by injectables, which meant GLP-1 producers needed not only drug supply, but also injection-specific components and presentation materials
A licensed pharmacist can still compound tirzepatide for a named patient with a valid prescription when there is a documented clinical need the FDA-approved product doesnt meet
Image items used in this work were created in BioRender: Ethics declarations Competing interests The authors declare no competing interests
Source: Novo Nordisk For example, Novo Nordisks own estimates show there are almost 430 million people with a body mass index above 35
It is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled
The tests high specificity (93%) and good sensitivity (78%), combined with its ease of use, make it a valuable tool for early detection of DPN, potentially leading to improved foot care and reduced risk of DFU